Skip to main content

Table 3 Comparison of the disease severity, the virus negative conversion time and the prognosis among the four subgroups (n = 95)

From: Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus

Variable Non-DM group (n = 76) DM group (n = 19) χ2or F score P score
Non-severe subgroup
(n = 57) 		Severe subgroup
(n = 19) 		Non-severe subgroup
(n = 8) 		Severe subgroup
(n = 11)
virus negative conversion time 18.49 ± 10.02 20.53 ± 9.25 28.00 ± 12.84 27.73 ± 9.57 4.097 0.009
In-hospital time 14.25 ± 8.72 17.79 ± 12.33 19.38 ± 8.12 29.27 ± 16.59 6.704  < 0.0001
Severe(case, %) 19(25.00) 11(61.11) -2.940 0.003
Prognosis    -3.394 0.001
 Cured (case, %) 53(71.05) 5(26.32)
 Unhealed 21(26.32) 13(68.42)
 Death 2(2.63) 1(5.26)
  1. FPG, fasting plasma glucose; HbA1c, glycated hemoglobin A1c; DM, diabetes mellitus; non-DM, without diabetes mellitus
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us